Press Releases

Press Releases

May 01, 2019

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Apr 29, 2019

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results

Apr 16, 2019

CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia

Apr 01, 2019

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Mar 06, 2019

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Feb 27, 2019

CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2019 Annual Meeting

Feb 25, 2019

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

Feb 25, 2019

CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001

Feb 21, 2019

CRISPR Therapeutics Proposes New Members to the Board of Directors

Feb 19, 2019

CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement

Jan 22, 2019

CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies

Jan 04, 2019

CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease